{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:29:43Z","timestamp":1787164183164,"version":"build-2736575974"},"reference-count":19,"publisher":"Pleiades Publishing Ltd","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dokl Biochem Biophys"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1134\/s1607672925700267","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T19:19:14Z","timestamp":1774898354000},"page":"93-98","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and Safety of Long-term Administration of Various Doses of Colchicine in Patients with Gout"],"prefix":"10.1134","volume":"526","author":[{"given":"M. S.","family":"Eliseev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. N.","family":"Chikina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. I.","family":"Kuzmina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. V.","family":"Panina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. L.","family":"Nasonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"7803_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.14412\/1995-4484-2004-1374","volume":"42","author":"V.A. Nasonova","year":"2004","unstructured":"Nasonova, V.A. and Barskova, V.G., Early diagnostic and treatment of gout is scientifically based requirements for improvement of labor and living prognosis of patients, Nauchno-Prakt. Revmatol., 2004, vol. 42, no.\u00a01, pp. 5\u20137. https:\/\/doi.org\/10.14412\/1995-4484-2004-1374","journal-title":"Nauchno-Prakt. Revmatol."},{"key":"7803_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.14412\/1996-7012-2020-2-97-103","volume":"14","author":"M.N. Chikina","year":"2020","unstructured":"Chikina, M.N., Eliseev, M.S., Zhelyabina, O.V., Eliseev, M.S., and Zhelyabina, O.V., Practical application of national clinical guidelines for the management of gout (preliminary data), Sovrem. Revmatol., 2020, vol.\u00a014, no. 2, pp. 97\u2013103. https:\/\/doi.org\/10.14412\/1996-7012-2020-2-97-103","journal-title":"Sovrem. Revmatol."},{"key":"7803_CR3","doi-asserted-by":"publisher","first-page":"760","DOI":"10.14412\/1995-4484-2018-760-766","volume":"56","author":"M.N. Chikina","year":"2018","unstructured":"Chikina, M.N., Prevention of arthritis attacks in the use of urate-lowering therapy in patients with gout, Nauchno-Prakt. Revmatol., 2018, vol. 56, no. 6, pp.\u00a0760\u2013766. https:\/\/doi.org\/10.14412\/1995-4484-2018-760-766","journal-title":"Nauchno-Prakt. Revmatol."},{"key":"7803_CR4","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s10067-019-04566-6","volume":"38","author":"C.A. Janssen","year":"2019","unstructured":"Janssen, C.A., Oude Voshaar, M.A.H., Ten Klooster,\u00a0P.M., Vonkeman, H.E., and van de Laar, M.A.F.J., Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare, Clin. Rheumatol., 2019, vol. 38, no. 8, pp. 2233\u20132239. https:\/\/doi.org\/10.1007\/s10067-019-04566-6","journal-title":"Clin. Rheumatol."},{"key":"7803_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.14412\/1996-7012-2021-2-50-56","volume":"15","author":"M.N. Chikina","year":"2021","unstructured":"Chikina, M.N., Eliseev, M.S., Zhelyabina, O.V., Eliseev, M.S., and Zhelyabina, O.V., Comparison of the efficacy and safety of various anti-inflammatory drugs in urate-lowering therapy initiation in patients with gout (preliminary data), Sovrem. Revmatol., 2021, vol.\u00a015, no. 2, pp. 50\u201356. https:\/\/doi.org\/10.14412\/1996-7012-2021-2-50-56","journal-title":"Sovrem. Revmatol."},{"key":"7803_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.47360\/1995-4484-2024-445-464","volume":"62","author":"E.L. Nasonov","year":"2024","unstructured":"Nasonov, E.L. and Drapkina, O.M., Colchicine: Repositioning an \u201cancient\u201d medicine in the 21st century, Nauchno-Prakt. Revmatol., 2024, vol. 62, no. 5, pp.\u00a0445\u2013464. https:\/\/doi.org\/10.47360\/1995-4484-2024-445-464","journal-title":"Nauchno-Prakt. Revmatol."},{"key":"7803_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/art.1780170517","volume":"17","author":"H.E. Paulus","year":"1974","unstructured":"Paulus, H.E., Schlosstein, L.H., Godfrey, R.G., Klinenberg, J.R., and Bluestone, R., Prophylactic colchicine therapy of intercritical gout. A placebo-controlled study of probenecid-treated patients, Arthritis Rheum., 1974, vol. 17, no. 5, pp. 609\u2013614. https:\/\/doi.org\/10.1002\/art.1780170517","journal-title":"Arthritis Rheum."},{"key":"7803_CR8","first-page":"2429","volume":"31","author":"G.C. Borstad","year":"2004","unstructured":"Borstad, G.C., Bryant, L.R., Abel, M.P., Scroggie, D.A., Harris, M.D., et al., Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis, J. Rheumatol., 2004, vol. 31, no. 12, pp. 2429\u20132432.","journal-title":"J. Rheumatol."},{"key":"7803_CR9","first-page":"104","volume":"11","author":"H. Karimzadeh","year":"2006","unstructured":"Karimzadeh, H., Nazari, J., Mottaghi, P., and Kabiri, P., Different duration of colchicine for preventing recurrence of gouty arthritis, J. Res. Med. Sci., 2006, vol. 11, pp. 104\u2013107.","journal-title":"J. Res. Med. Sci."},{"key":"7803_CR10","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1016\/j.clinthera.2011.01.008","volume":"32","author":"R.L. Wortmann","year":"2010","unstructured":"Wortmann, R.L., Macdonald, P.A., Hunt, B., and Jackson, R.L., Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials, Clin. Ther., 2010, vol. 32, no.\u00a014, pp. 2386\u20132397. https:\/\/doi.org\/10.1016\/j.clinthera.2011.01.008","journal-title":"Clin. Ther."},{"key":"7803_CR11","doi-asserted-by":"publisher","unstructured":"Mckenzie, B.J., Wechalekar, M.D., Johnston, R.V., Schlesinger, N., and Buchbinder, R., Colchicine for acute gout, Cochrane Database Syst. Rev., 2021, vol. 8, no. 8, p. cd006190. https:\/\/doi.org\/10.1002\/14651858.CD006190.pub3","DOI":"10.1002\/14651858.CD006190.pub3"},{"key":"7803_CR12","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1161\/atvbaha.124.319851","volume":"44","author":"L.F. Buckley","year":"2024","unstructured":"Buckley, L.F. and Libby, P., Colchicine\u2019s role in cardiovascular disease management, Arterioscler., Thromb., Vasc. Biol., 2024, vol. 44, no. 5, pp. 1031\u20131041. https:\/\/doi.org\/10.1161\/atvbaha.124.319851","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"7803_CR13","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s40261-022-01209-8","volume":"42","author":"A. Van Broekhoven","year":"2022","unstructured":"Van Broekhoven, A., Mohammadnia, N., Silvis, M.J.M., Los, J., Fiolet, A.T.L., Opstal, T.S.J., Mosterd, A., Eikelboom, J.W., Nidorf, S.M., Budgeon, Ch.A., Byrnes, E., Bax, W.A., Tijssen, J.G.P., De Kleijn, D.P.V., Thompson, P.L., El Messaoudi, S., and Cornel, J.H., The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial, Clin. Drug Invest., 2022, vol. 42, no. 11, pp. 977\u2013985. https:\/\/doi.org\/10.1007\/s40261-022-01209-8","journal-title":"Clin. Drug Invest."},{"key":"7803_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/annrheumdis-2019-215315","volume":"79","author":"P. Richette","year":"2020","unstructured":"Richette, P., Doherty, M., Pascual, E., Barskova, V., Becce, F., Castaneda, J., Coyfish, M., Guillo, S., Jansen, T., Janssens, H., Liot\u00e9, F., Mallen, Ch.D., Nuki, G., Perez-Ruiz, F., Pimentao, J., Punzi, L., Pywell, A., So,\u00a0\u00a0A.K., Tausche, A.-K., Uhlig, T., Zavada, J., Zhang, W., Tubach, F., and Bardin, T., 2018 Updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout, Ann. Rheumatic Dis., 2020, vol. 79, no. 1, pp. 31\u201338. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215315","journal-title":"Ann. Rheumatic Dis."},{"key":"7803_CR15","unstructured":"Assotsiatsiya revmatologov Rossii. Klinicheskie rekomendatsii. Podagra (Association of Rheumatologists of Russia. Clinical Recommendations. Gout), 2018."},{"key":"7803_CR16","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/art.40381","volume":"70","author":"A.L. Gaffo","year":"2018","unstructured":"Gaffo, A.L., Dalbeth, N., Saag, K.G., Singh, J.A., Rahn, E.J., Mudano, A.S., Chen, Yi., Lin, Ch., Bourke, S., Louthrenoo, W., Vazquez-mellado, J., Hern\u00e1ndez-llinas, H., Neogi, T., Vargas-santos, A.B., Da Rocha Castelar-pinheiro, G., Amorim, R.B.C., Uhlig, T., Hammer, H.B., Eliseev, M., Perez-ruiz, F., Cavagna, L., Mccarthy, G.M., Stamp, L.K., Gerritsen, M., Fana, V., Sivera, F., and Taylor, W., Brief report: validation of a definition of flare in patients with established gout, Arthritis Rheumatol., 2018, vol. 70, no.\u00a03, pp. 462\u2013467. https:\/\/doi.org\/10.1002\/art.40381","journal-title":"Arthritis Rheumatol."},{"key":"7803_CR17","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/s0140-6736(74)90884-8","volume":"304","author":"E.C. Huskisson","year":"1974","unstructured":"Huskisson, E.C., Measurement of pain, Lancet, 1974, vol. 304, no. 7889, pp. 1127\u20131131. https:\/\/doi.org\/10.1016\/s0140-6736(74)90884-8","journal-title":"Lancet"},{"key":"7803_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.14412\/1996-7012-2021-4-50-55","volume":"15","author":"M.S. Eliseev","year":"2021","unstructured":"Eliseev, M.S., Chikina, M.N., Zhelyabina, O.V., Eliseev, M.S., Chikina, M.N., and Zhelyabina, O.V., Colchicine for acute arthritis attacks prevention in patients with gout during urate-lowering therapy (results of a pilot study), Sovrem. Revmatol., 2021, vol. 15, no. 4, pp.\u00a050\u201355. https:\/\/doi.org\/10.14412\/1996-7012-2021-4-50-55","journal-title":"Sovrem. Revmatol."},{"key":"7803_CR19","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3390\/jcm9051488","volume":"9","author":"Y.-J. Oh","year":"2020","unstructured":"Oh, Y.-J. and Moon, K.W., Combined use of febuxostat and colchicine does not increase acute hepatotoxicity in patients with gout: a retrospective study, J. Clin. Med., 2020, vol. 9, no. 5, p. 1488. https:\/\/doi.org\/10.3390\/jcm9051488","journal-title":"J. Clin. Med."}],"container-title":["Doklady Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672925700267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S1607672925700267","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672925700267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:49:34Z","timestamp":1778590174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S1607672925700267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7803"],"URL":"https:\/\/doi.org\/10.1134\/s1607672925700267","relation":{},"ISSN":["1607-6729","1608-3091"],"issn-type":[{"value":"1607-6729","type":"print"},{"value":"1608-3091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local ethics committee of the Nasonova Research Institute of Rheumatology (protocol no. 07 dated March 23, 2023). All study participants read and signed voluntary informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"ETHICS APPROVAL AND CONSENT TO PARTICIPATE"}},{"value":"The authors of this work declare that they have no conflicts of interest. The authors did not receive any royalties for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"CONFLICT OF INTEREST"}}]}}